Maurizio Pastorello

Palermo, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Real-World Progression-Free Survival and Healthcare Resource Utilization Associated with Daratumumab Use in Transplant-Ineligible Multiple Myeloma Patients in Italy.

Real-World Progression-Free Survival and Healthcare Resource Utilization Associated with Daratumumab Use in Transplant-Ineligible Multiple Myeloma Patients in Italy.

Journal: ClinicoEconomics and outcomes research : CEOR

Published: November 29, 2025

Characteristics, therapeutic pathway and the economic burden of patients with drug-resistant epilepsy: A real-world analysis following the introduction of cenobamate in Italy.

Characteristics, therapeutic pathway and the economic burden of patients with drug-resistant epilepsy: A real-world analysis following the introduction of cenobamate in Italy.

Journal: Epilepsia

Published: May 20, 2025

Frequency of anticholinergic drug use in patients treated with aripiprazole once-monthly: a 2-year cohort study using European healthcare databases.

Frequency of anticholinergic drug use in patients treated with aripiprazole once-monthly: a 2-year cohort study using European healthcare databases.

Journal: Therapeutic advances in psychopharmacology

Published: December 23, 2024

Characteristics and Drug Utilization of Patients with Hereditary Angioedema in Italy, a Real-World Analysis.

Characteristics and Drug Utilization of Patients with Hereditary Angioedema in Italy, a Real-World Analysis.

Journal: Healthcare (Basel, Switzerland)

Published: June 12, 2023

Comparison of Direct Oral Anticoagulant Use for the Treatment of Non-Valvular Atrial Fibrillation in Pivotal Clinical Trials vs. the Real-World Setting: A Population-Based Study from Southern Italy.

Comparison of Direct Oral Anticoagulant Use for the Treatment of Non-Valvular Atrial Fibrillation in Pivotal Clinical Trials vs. the Real-World Setting: A Population-Based Study from Southern Italy.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: February 10, 2021

Real World Use of Antidiabetic Drugs in the Years 2011-2017: A Population-Based Study from Southern Italy.

Real World Use of Antidiabetic Drugs in the Years 2011-2017: A Population-Based Study from Southern Italy.

Journal: International journal of environmental research and public health

Published: November 19, 2020

In Search of Predictors of Switching Between Erythropoiesis-Stimulating Agents in Clinical Practice: A Multi-Regional Cohort Study.

In Search of Predictors of Switching Between Erythropoiesis-Stimulating Agents in Clinical Practice: A Multi-Regional Cohort Study.

Journal: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy

Published: October 09, 2019

Direct healthcare costs of chronic kidney disease management in Italy: What cost-savings can be achieved with higher biosimilar uptake and more appropriate use of erythropoiesis-stimulating agents?

Direct healthcare costs of chronic kidney disease management in Italy: What cost-savings can be achieved with higher biosimilar uptake and more appropriate use of erythropoiesis-stimulating agents?

Journal: Pharmacoepidemiology and drug safety

Published: September 16, 2019

Effectiveness and Safety of Switching Originator and Biosimilar Epoetins in Patients with Chronic Kidney Disease in a Large-Scale Italian Cohort Study.

Effectiveness and Safety of Switching Originator and Biosimilar Epoetins in Patients with Chronic Kidney Disease in a Large-Scale Italian Cohort Study.

Journal: Drug safety

Published: June 23, 2019

Role of healthcare databases and registries for surveillance of orphan drugs in the real-world setting: the Italian case study.

Role of healthcare databases and registries for surveillance of orphan drugs in the real-world setting: the Italian case study.

Journal: Expert opinion on drug safety

Published: May 07, 2019

Non-persistence risk and health care resource utilization of Italian patients with non-valvular atrial fibrillation

Non-persistence risk and health care resource utilization of Italian patients with non-valvular atrial fibrillation

Journal: Recenti progressi in medicina

Published: March 02, 2018

Pattern of Use of Biosimilar and Originator Somatropin in Italy: A Population-Based Multiple Databases Study During the Years 2009-2014.

Pattern of Use of Biosimilar and Originator Somatropin in Italy: A Population-Based Multiple Databases Study During the Years 2009-2014.

Journal: Frontiers in endocrinology

Published: December 14, 2017

Showing 1-12 of 16

Last Updated: 09/26/2026